Oct. 25, 2021
Oct. 25, 2021
NIH What’s New | COVID-19 Treatment Guidelines
Oct. 25, 2021
The FDA is proposing to establish a regulatory category for over-the-counter hearing aids (Federal Register)
Oct. 25, 2021
FDA Takes Additional Actions on the Use of a Booster Dose for COVID-19 Vaccines
Oct. 21, 2021
Lupin Pharmaceuticals, Inc. Issues Voluntarily Nationwide Recall of All Irbesartan Tablets and Irbesartan and Hydrochlorothiazide Tablets Due to Potential Presence of N-nitrosoirbesartan Impurity | FDA
Oct. 21, 2021
Potential for False Positive Results with Abbott Molecular Inc. Alinity m SARS-CoV-2 AMP and Alinity m Resp-4-Plex AMP Kits – Letter to Clinical Laboratory Staff and Health Care Providers | FDA
Oct. 21, 2021
VRBPAC October 26, 2021 Meeting Announcement
Oct. 21, 2021
Citation and Notification of Penalty
Oct. 20, 2021
FDA Advisors Vote to Recommend Moderna Boosters
Oct. 20, 2021